Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users | Zendy

Judith I. Tsui | Zendy; Jennifer L. Evans | Zendy; Paula J. Lum | Zendy; Judith A. Hahn | Zendy; Kimberly Page | Zendy

Open Access

Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users

Author(s) -

Judith I. Tsui,

Jennifer L. Evans,

Paula J. Lum,

Judith A. Hahn,

Kimberly Page

Publication year - 2014

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2014.5416

Subject(s) - medicine , incidence (geometry) , agonist , hepatitis c virus , opioid , injection drug use , hepatitis c , drug , virology , pharmacotherapy , pharmacology , virus , drug injection , receptor , physics , optics

Injection drug use is the primary mode of transmission for hepatitis C virus (HCV) infection. Prior studies suggest opioid agonist therapy may reduce the incidence of HCV infection among injection drug users; however, little is known about the effects of this therapy in younger users.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research